Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancerChristoph A. Fink, Juliane Hörner‐Rieber, Philipp Hoegen et al.|Frontiers in Oncology|2024Cited by 10
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trialChristoph A. Fink, Stefan A. Koerber, Jonas Ristau et al.|Clinical and Translational Radiation Oncology|2024Cited by 4